Jianbin Bi - Publications, H-index & Citations

Jianbin Bi

China Medical University

26H指数

94论文数

1.5K被引数

收录论文 33

发表时间

Mechanism and therapeutic significance of ARV-110 combined with a PDGFR inhibitor for the induction of apoptosis in castration-resistant prostate cancer cells through the ROS/JNK pathway ARV-110与PDGFR抑制剂联合通过ROS/JNK通路诱导去势抵抗性前列腺癌细胞凋亡的机制及治疗意义

Cell Death & Disease

IF9.6

2026-04-10

OAAI

Yang Fu; Shanshan Sun; Guangxu Liu; Qingzhuo Dong; Yutao Wang; Haoyuan Zheng; Chiyuan Piao; Jianbin Bi

Case Report: Two cases of chemotherapy refractory aggressive variant prostate cancer with extreme durable response to PARP inhibitor 病例报告：两例对化疗耐药的侵袭性变异型前列腺癌患者，对PARP抑制剂表现出极耐久的反应。

FRONTIERS IN ONCOLOGY

IF3.3

2025-04-24

OAAI

Jiang, Bohao; Bi, Yifan; Chen, Yiming; Bi, Jianbin; Deng, Jian; Zhang, Gejun

Comparative therapeutic efficacy and safety of first-line and second-line therapies for metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis 转移性去势抵抗性前列腺癌的一线和二线疗法比较疗效与安全性：一项系统评价和网络meta分析

ECLINICALMEDICINE

IF10

2025-03-01

OAAI

Jiang, Bohao; Wang, Benqiao; Chen, Yiming; Chen, Yaang; Li, Bohan; Bi, Jianbin

An online clustering algorithm predicting model for prostate cancer based on PHI-related variables and PI-RADS in different PSA populations

CANCER CELL INTERNATIONAL

IF6

2025-02-13

OAAI

Hu, Jiyuan; Miao, Qi; Ren, Jiayi; Su, Hongbo; Zhang, Xianlu; Bi, Jianbin; Zhang, Gejun

Diagnostic Performance of PET/CT Using Different Radiotracers in Clinically Significant Primary Prostate Cancer: A Systematic Review and Network Meta-analysis PET/CT在不同放射性示踪剂下对临床显著原发性前列腺癌的诊断性能：一项系统评价和网络Meta分析

Academic Radiology

IF3.9

2025-02-05

PREAI

Yiming Chen; Xianlu Zhang; Jianbin Bi; Jianfeng Wang

The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registries 接受经尿道切除术的非肌层浸润性膀胱癌患者的肿瘤位置对预后的影响: 一项利用中国多中心和SEER注册表的队列研究的见解

INTERNATIONAL JOURNAL OF SURGERY

IF10.1

2024-09-01

OAAI

Liu, Lilong; Li, Kaiwen; Wang, Shao-gang; Wang, Jianli; Yao, Zhipeng; Xie, Yu; Ji, Zhigang; Chen, Zhiwen; Hu, Hailong; Chen, Haige; Hu, Junyi; Hou, Yaxin; Liu, Zhenghao; Li, Yang; Ding, Yuhong; Kuang, Yingchun; Xun, Yang; Hu, Jia; Zhang, Jiaqiao; Li, Heng; Chong, Tie; Bi, Jianbin; Wang, Zhiping; Wang, Yinhuai; Zhang, Peng; Wei, Qiang; Chen, Zhaohui; Li, Lei; Huang, Jian; Liu, Zheng; Chen, Ke

In vitro and in vivo assessment of a bilayered degradable rapamycin-eluting stent for ureteral stricture caused by holmium: YAG laser lithotripsy 双层可降解雷帕霉素洗脱支架治疗钬激光碎石致输尿管狭窄的体内外评价

ACTA BIOMATERIALIA

IF9.6

2023-12-01

OAAI

Hu, Jiyuan; Wang, Zhenyu; Hu, Hao; Zhao, Jing; Li, Hongwei; Zhang, Xinyu; Bi, Jianbin; Li, Jianzhong

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1

FRONTIERS IN MEDICINE

IF3

2023-08-08

OAAI

Shen, Junlin; Du, Mingyang; Liang, Shuang; Wang, Linhui; Bi, Jianbin

Identification of fatty acid metabolism-based molecular subtypes and prognostic signature to predict immune landscape and guide clinical drug treatment in renal clear cell carcinoma

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-03-01

OAAI

Wang, Linhui; Shen, Junlin; Wang, Yutao; Bi, Jianbin

Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma

BMC CANCER

IF3.4

2023-02-16

OAAI

Shen, Junlin; Wang, Linhui; Bi, Jianbin

A novel focal adhesion-related risk model predicts prognosis of bladder cancer -- a bioinformatic study based on TCGA and GEO database

BMC CANCER

IF3.4

2022-11-10

OAAI

Hu, Jiyuan; Wang, Linhui; Li, Luanfeng; Wang, Yutao; Bi, Jianbin

In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer

FUNCTIONAL & INTEGRATIVE GENOMICS

IF3.1

2022-07-28

OAAI

Wang, Linhui; Wang, Yutao; Bi, Jianbin

PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3 (vol 27, pg 412, 2020)

CANCER GENE THERAPY

IF5

2022-03-31

OAAI

Gao, Zhipeng; Man, Xiaojun; Li, Zhenhua; Bi, Jianbin; Liu, Xiankui; Li, Zeliang; Li, Jun; Zhang, Zhe; Kong, Chuize

Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes

JOURNAL OF IMMUNOLOGY RESEARCH

IF3.6

2021-10-18

OAAI

Wang, Linhui; Wang, Yutao; Wang, Jianfeng; Li, Luanfeng; Bi, Jianbin

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2021-09-27

OAAI

Sun, Siqing; Wang, Yutao; Wang, Jianfeng; Bi, Jianbin

A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer

BMC CANCER

IF3.4

2021-07-15

OAAI

Fu, Yang; Sun, Shanshan; Bi, Jianbin; Kong, Chuize; Yin, Lei

Genome instability-related long non-coding RNA in clear renal cell carcinoma determined using computational biology

BMC CANCER

IF3.4

2021-06-24

OAAI

Wang, Yutao; Yan, Kexin; Wang, Linhui; Bi, Jianbin

M2 Macrophage Co-Expression Factors Correlate With Immune Phenotype and Predict Prognosis of Bladder Cancer M2型巨噬细胞共表达因子与膀胱癌免疫表型及预后的相关性研究

FRONTIERS IN ONCOLOGY

IF3.3

2021-03-22

OAAI

Wang, Yutao; Yan, Kexin; Wang, Jianfeng; Lin, Jiaxing; Bi, Jianbin

An 18-gene signature based on glucose metabolism and DNA methylation improves prognostic prediction for urinary bladder cancer 基于葡萄糖代谢和DNA甲基化的18基因签名可改善膀胱癌的预后预测

GENOMICS

IF3

2021-01-01

OAAI

Liu, Zhuonan; Sun, Tianshui; Zhang, Zhe; Bi, Jianbin; Kong, Chuize

CD8+T Cell Co-Expressed Genes Correlate With Clinical Phenotype and Microenvironments of Urothelial Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2020-11-19

OAAI

Wang, Yutao; Yan, Kexin; Lin, Jiaxing; Liu, Yang; Wang, Jianfeng; Li, Xuejie; Li, Xinxin; Hua, Zhixiong; Zheng, Zhenhua; Shi, Jianxiu; Sun, Siqing; Bi, Jianbin

研究方向